Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hudie Wei

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|May 9, 2025
Structural analysis of apoptotic MCL1-HRK complexJiaqi Wang, Longying Jiang, Hudie Wei
Computational and Structural Biotechnology Journal|August 10, 2023
Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteinsHaolan Wang, Ming Guo, Hudie Wei, et al.
Iscience|September 2, 2025
Molecular mechanisms underlying HRK interaction with BCL-XL and BCL-2 reveal specificity determinants for BH3 mimeticsJiaqi Wang, Ming Guo, Shuyan Dai, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
Targeting p53 pathways: mechanisms, structures, and advances in therapyHaolan Wang, Ming Guo, Hudie Wei, et al.
Journal of Hematology & Oncology|April 22, 2021
Targeting MCL-1 in cancer: current status and perspectivesHaolan Wang, Ming Guo, Hudie Wei, et al.
Computational and Structural Biotechnology Journal|May 17, 2021
Farnesoid X receptor (FXR): Structures and ligandsLongying Jiang, Huajun Zhang, Desheng Xiao, et al.
Computational and Structural Biotechnology Journal|March 23, 2022
Corrigendum to: "Farnesoid X receptor (FXR): Structures and ligands" [Comput. Struct. Biotechnol. J. 19 (2021) 2148-2159]Longying Jiang, Huajun Zhang, Desheng Xiao, et al.
Communications Chemistry|January 25, 2023
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutantsQianmeng Lin, Xiaojuan Chen, Lingzhi Qu, et al.
Biochemical and Biophysical Research Communications|January 29, 2022
Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptorLongying Jiang, Xueke Liu, Hudie Wei, et al.
Biochemical and Biophysical Research Communications|February 26, 2022
Corrigendum to "Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor" [Biochem. Biophys. Res. Commun. 595(5) 2022 1-6]Longying Jiang, Xueke Liu, Hudie Wei, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|May 9, 2025
Structural analysis of apoptotic MCL1-HRK complexJiaqi Wang, Longying Jiang, Hudie Wei
Computational and Structural Biotechnology Journal|August 10, 2023
Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteinsHaolan Wang, Ming Guo, Hudie Wei, et al.
Iscience|September 2, 2025
Molecular mechanisms underlying HRK interaction with BCL-XL and BCL-2 reveal specificity determinants for BH3 mimeticsJiaqi Wang, Ming Guo, Shuyan Dai, et al.
Signal Transduction and Targeted Therapy|March 1, 2023
Targeting p53 pathways: mechanisms, structures, and advances in therapyHaolan Wang, Ming Guo, Hudie Wei, et al.
Journal of Hematology & Oncology|April 22, 2021
Targeting MCL-1 in cancer: current status and perspectivesHaolan Wang, Ming Guo, Hudie Wei, et al.
Computational and Structural Biotechnology Journal|May 17, 2021
Farnesoid X receptor (FXR): Structures and ligandsLongying Jiang, Huajun Zhang, Desheng Xiao, et al.
Computational and Structural Biotechnology Journal|March 23, 2022
Corrigendum to: "Farnesoid X receptor (FXR): Structures and ligands" [Comput. Struct. Biotechnol. J. 19 (2021) 2148-2159]Longying Jiang, Huajun Zhang, Desheng Xiao, et al.
Communications Chemistry|January 25, 2023
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutantsQianmeng Lin, Xiaojuan Chen, Lingzhi Qu, et al.
Biochemical and Biophysical Research Communications|January 29, 2022
Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptorLongying Jiang, Xueke Liu, Hudie Wei, et al.
Biochemical and Biophysical Research Communications|February 26, 2022
Corrigendum to "Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor" [Biochem. Biophys. Res. Commun. 595(5) 2022 1-6]Longying Jiang, Xueke Liu, Hudie Wei, et al.
Pageof 4